Abstract:Toxoplasma gondii is an obligate intracellular parasite that infects one-third of the world's human population and establishes infection in the brain. Cerebral immune cell infiltration is critical for controlling the parasite, but little is known about the molecular cues guiding immune cells to the brain during infection. Activated astrocytes produce CCL2, a chemokine that mediates inflammatory monocyte recruitment to tissues by binding to the CCR2 receptor. We detected elevated CCL2 production in the brains of C57BL/6J mice by 15 days after T . gondii infection. Utilizing confocal microscopy and intracellular flow cytometry, we identified microglia and brain-infiltrating myeloid cells as the main producers of CCL2 during acute infection, and CCL2 was specifically produced in regions of parasite infection in the brain. In contrast, astrocytes became the dominant CCL2 producer during chronic T . gondii infection. To determine the role of astrocyte-derived CCL2 in mobilizing immune cells to the brain and controlling T . gondii infection, we generated GFAP-Cre x CCL2 fl/fl mice, in which astrocytes are deficient in CCL2 production. We observed significantly decreased immune cell recruitment and increased parasite burden in the brain during chronic, but not acute, infection of mice deficient in astrocyte CCL2 production, without an effect on peripheral immune responses. To investigate potential mechanisms explaining the reduced control of T . gondii infection, we analyzed key antimicrobial and immune players in host defense against T . gondii and detected a reduction in iNOS + myeloid cells, and T . gondii -specific CD4 + T cells in the knockout mice. These data uncover a critical role for astrocyte-derived CCL2 in immune cell recruitment and parasite control in the brain during chronic, but not acute, T . gondii infection. Neuroinflammation plays an important role in protecting the brain against infection, but it must be controlled to prevent damage to the brain. Toxoplasma gondii is an obligate intracellular foodborne parasite that infects one-third of the world's human population. Among pathogens, T . gondii has the rare ability to cross the blood-brain barrier and establish chronic infection in the brain, inducing a protective, but non-sterilizing immune response. In this study, we examined T . gondii infection of mice to understand the factors driving the neuroinflammatory response to infection of the brain. We determined that the cells producing the potent chemokine, CCL2, changed over the course of infection: myeloid cells were the main CCL2 producers during acute infection, whereas astrocytes became the dominant CCL2 producers during chronic infection. Additionally, the ablation of CCL2 production specifically from astrocytes reduced immune cell recruitment to the brain and decreased control of the parasite during chronic infection. Therefore, astrocyte-derived CCL2 plays a critical role in the control of chronic, but not acute, T . gondii infection.

Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection

Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease

Cis-acting Lnc-Cxcl2 Restrains Neutrophil-Mediated Lung Inflammation by Inhibiting Epithelial Cell CXCL2 Expression in Virus Infection

TLR2 Senses the SARS-CoV-2 Envelope Protein to Produce Inflammatory Cytokines

Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice

Lymphocytic Choriomeningitis Virus (LCMV) Infection of CNS Glial Cells Results in TLR2-MyD88/Mal-dependent Inflammatory Responses

Cxcl10 is required for survival during SARS-CoV-2 infection in mice

Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy

Mice Overexpressing Chemokine Ligand 2 (CCL2) in Astrocytes Display Enhanced Nociceptive Responses

Dual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell–Mediated Viral Clearance

Sustained Infiltration of Neutrophils Into the CNS Results in Increased Demyelination in a Viral-Induced Model of Multiple Sclerosis

The CXCL10/CXCR3 Axis Promotes Disease Pathogenesis in Mice upon CVA2 Infection

Deficiency in astrocyte CCL2 production reduces neuroimmune control of Toxoplasma gondii infection

C-C motif chemokine receptor 2 and 7 synergistically control inflammatory monocyte recruitment but the infecting virus dictates monocyte function in the brain

CCR2 mediates increased susceptibility to post-H1N1 bacterial pneumonia by limiting dendritic cell induction of IL-17

TNF-α exacerbates SARS-CoV-2 infection by stimulating CXCL1 production from macrophages

Cystatin F attenuates neuroinflammation and demyelination following murine coronavirus infection of the central nervous system

Gene Therapy with CCL2 (MCP-1) Mutant Protects CVB3-induced Myocarditis by Compromising Th1 Polarization.

Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells

Highly Activated Cytotoxic CD8 T Cells Express Protective IL-10 at the Peak of Coronavirus-Induced Encephalitis